Search by Drug Name or NDC

    NDC 51660-0753-31 Loratadine 5 mg/1 Details

    Loratadine 5 mg/1

    Loratadine is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Ohm Laboratories Inc.. The primary component is LORATADINE.

    Product Information

    NDC 51660-0753
    Product ID 51660-753_48a60b3d-d011-4d0f-84dc-414c713c76ba
    Associated GPIs
    GCN Sequence Number 062340
    GCN Sequence Number Description loratadine TAB CHEW 5 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 98118
    HICL Sequence Number 007605
    HICL Sequence Number Description LORATADINE
    Brand/Generic Generic
    Proprietary Name Loratadine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Loratadine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, CHEWABLE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name LORATADINE
    Labeler Name Ohm Laboratories Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210088
    Listing Certified Through 2024-12-31

    Package

    NDC 51660-0753-31 (51660075331)

    NDC Package Code 51660-753-31
    Billing NDC 51660075331
    Package 3 BLISTER PACK in 1 CARTON (51660-753-31) / 10 TABLET, CHEWABLE in 1 BLISTER PACK
    Marketing Start Date 2018-06-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.404
    Pricing Unit EA
    Effective Date 2022-05-18
    NDC Description CHILD LORATADINE 5 MG TAB CHEW
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL b83de07d-37f4-42b4-b43e-29173454bef0 Details

    Revised: 7/2019